Thu, Sep 3 06:34 PM

BTIG raises Climb Bio stock price target to $32 on phase 1 data

Investing.com•Thu, Sep 3, 2026, 06:06 PM•2 min read

Developing story — details emerging. Check the source link for the latest updates.

Source: [Investing.com](https://www.investing.com/news/analyst-ratings/btig-raises-climb-bio-stock-price-target-to-32-on-phase-1-data-93CH-4888386)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at Investing.com ↗

#finance #btig #raises #climb #bio #stock #price #target #phase

More Headlines

FinanceMarketWatch• 10m ago

New doubts emerge about whether Fed will raise interest rates this month

Fed governor Christopher Waller made a strong case for the Fed to hold rates steady.

FinanceSeeking Alpha• 14m ago

Bank of England To Diverge From The Fed As Inflation Remains Cool

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 15m ago

New York Fashion Week leans into American legacy brand revival

Developing story — details emerging. Check the source link for the latest updates.

FinanceBloomberg Markets• 16m ago

Polymarket Launches Perpetual Oil Futures in 24/7 Trading Push

Polymarket has launched perpetual futures contracts tied to oil, stepping into a market that rival Kalshi Inc. is also seeking to enter as trading venues compete to offer round-the-clock access to the commodity.

FinanceInvesting.com• 18m ago

Flexsteel CIO McClaflin sells $203,625 of FLXS shares

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 18m ago

Old Republic SVP Carolyn Monroe sells $184k of ORI common stock

Developing story — details emerging. Check the source link for the latest updates.